We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Advanced Melanoma

Journal Scan / Research · October 28, 2019

Older and Younger Patients Treated With Immune Checkpoint Inhibitors Have Similar Outcomes in a Real-Life Setting

European Journal of Cancer

 

Additional Info

European Journal of Cancer
Older and Younger Patients Treated With Immune Checkpoint Inhibitors Have Similar Outcomes in Real-Life Setting
Eur. J. Cancer 2019 Nov 01;121(xx)192-201, P Corbaux, D Maillet, A Boespflug, M Locatelli-Sanchez, M Perier-Muzet, M Duruisseaux, L Kiakouama-Maleka, S Dalle, C Falandry, J Péron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading